A New Era in the Treatment of Myasthenia Gravis: Six New Medications in The Last 6 Years
Article in Current Treatment Options in Neurology (January 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study
Article in European Journal of Neurology (October 2023)
Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity
Article in Neurology and Therapy (September 2023)